{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:31:18Z","timestamp":1791545478138,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100001415","name":"Medcen Community Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001415","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s11033-019-05222-7","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T07:02:35Z","timestamp":1575874955000},"page":"1207-1222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Steroidogenic acute regulatory protein\/aldosterone synthase mediates angiotensin II-induced cardiac fibrosis and hypertrophy"],"prefix":"10.1007","volume":"47","author":[{"given":"Wei-Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Hua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn","family":"Sturdivant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning-Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erskine A.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himangshu S.","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5333-8038","authenticated-orcid":false,"given":"Zhi-Qing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,9]]},"reference":[{"issue":"5","key":"5222_CR1","doi-asserted-by":"crossref","first-page":"R493","DOI":"10.1152\/ajpregu.00178.2014","volume":"307","author":"S J\u00f6nsson","year":"2014","unstructured":"J\u00f6nsson S, Agic MB, Narfstr\u00f6m F, Melville JM, Hultstr\u00f6m M (2014) Renal neurohormonal regulation in heart failure decompensation. Am J Physiology (Regul Integr Comp Physiol) 307(5):R493\u2013R497","journal-title":"Am J Physiology (Regul Integr Comp Physiol)"},{"issue":"5","key":"5222_CR2","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s11033-008-9262-z","volume":"36","author":"N Azarpira","year":"2009","unstructured":"Azarpira N, Bagheri M, Raisjalali GA, Aghdaie MH, Behzadi S, Salahi H, Rahsaz M, Darai M, Ashraf MJ, Geramizadeh B (2009) Angiotensinogen, angiotensine converting enzyme and plasminogenactivator inhibitor-1 gene polymorphism in chronic allograftdysfunction. Mol Biol Rep 36(5):909\u2013915","journal-title":"Mol Biol Rep"},{"issue":"9","key":"5222_CR3","first-page":"3899","volume":"29","author":"H Kadoya","year":"2015","unstructured":"Kadoya H, Satoh M, Sasaki T, Taniguchi S, Takahashi M, Kashihara N (2015) Excess aldosterone is a critical danger signal for inflammasome activation in the development of renal fibrosis in mice. FEBS J 29(9):3899\u20133910","journal-title":"FEBS J"},{"issue":"3","key":"5222_CR4","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.bbadis.2017.12.028","volume":"1864","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Yu J, Liu J, Cao R, Su W, Li S, Ye S, Zhu C, Zhang X, Xu H, Chen H, Zhang X, Guan Y (2018) Induction of cytochrome P450 4A14 contributes to angiotensin II-induced renal fibrosis in mice. Biochim Biophys Acta 1864(3):860\u2013870","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"5222_CR5","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1248\/bpb.b17-00291","volume":"40","author":"Y Hori","year":"2017","unstructured":"Hori Y, Touei D, Saitoh R, Yamagishi M, Kanai K, Hoshi F, Itoh N (2017) The aldosterone receptor antagonist eplerenone inhibits isoproterenol-induced collagen-I and 11\u03b2-HSD1 expression in rat cardiac fibroblasts and the left ventricle. Biol Pharm Bull 40(10):1716\u20131723","journal-title":"Biol Pharm Bull"},{"key":"5222_CR6","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1007\/s11033-019-04977-3","volume":"46","author":"M Catal\u00e1n","year":"2019","unstructured":"Catal\u00e1n M, Ar\u00e1nguiz P, Boza P, Olmedo I, Humeres C, Vivar R, Anfossi R, Ayala P, Espinoza C, Lavandero S, D\u00edaz-Araya G (2019) TGF-\u03b21 induced up-regulation of B1 kinin receptor promotesantifibrotic activity in rat cardiac myofibroblasts. Mol Biol Rep 46:5197\u20135207","journal-title":"Mol Biol Rep"},{"issue":"3","key":"5222_CR7","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/SHK.0000000000001132","volume":"51","author":"LW Yang","year":"2019","unstructured":"Yang LW, Qin DZ, James E, McKallip RJ, Wang NP, Zhang WW, Zheng RH, Han QH, Zhao ZQ (2019) CD44 deficiency in mice protects the heart against angiotensin II-induced cardiac fibrosis. Shock 51(3):372\u2013380","journal-title":"Shock"},{"issue":"3","key":"5222_CR8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jacc.2017.05.040","volume":"70","author":"SD Farris","year":"2017","unstructured":"Farris SD, Don C, Helterline D, Costa C, Plummer T, Steffes S, Mahr C, Mokadam NA, Stempien-Otero A (2017) Cell-specific pathways supporting persistent fibrosis in heart failure. J Am Coll Cardiol 70(3):344\u2013354","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"5222_CR9","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1210\/en.2016-1707","volume":"158","author":"JP Ball","year":"2017","unstructured":"Ball JP, Syed M, Mara\u00f1on RO, Hall ME, Kc R, Reckelhoff JF, Yanes Cardozo LL, Romero DG (2017) Role and regulation of microRNAs in aldosterone-mediated cardiac injury and dysfunction in male rats. Endocrinology 158(6):1859\u20131874","journal-title":"Endocrinology"},{"issue":"5","key":"5222_CR10","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/HYPERTENSIONAHA.114.04912","volume":"65","author":"SB Bender","year":"2015","unstructured":"Bender SB, DeMarco VG, Padilla J, Jenkins NT, Habibi J, Garro M, Pulakat L, Aroor AR, Jaffe IZ, Sowers JR (2015) Mineralocorticoid receptor antagonism treats obesity-associated cardiac diastolic dysfunction. Hypertension 65(5):1082\u20131088","journal-title":"Hypertension"},{"issue":"1","key":"5222_CR11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"Monticone S, D\u2019Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, Mulatero P (2018) Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrino 6(1):41\u201350","journal-title":"Lancet Diabetes Endocrino"},{"issue":"24","key":"5222_CR12","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1161\/CIRCULATIONAHA.106.634626","volume":"114","author":"F Beygui","year":"2006","unstructured":"Beygui F, Collet JP, Benoliel JJ, Vignolles N, Dumaine R, Barth\u00e9l\u00e9my O, Montalescot G (2006) High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction. Circulation 114(24):2604\u20132610","journal-title":"Circulation"},{"issue":"3","key":"5222_CR13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1530\/JOE-16-0452","volume":"232","author":"C Chong","year":"2017","unstructured":"Chong C, Hamid A, Yao T, Garza AE, Pojoga LH, Adler GK, Romero JR, Williams GH (2017) Regulation of aldosterone secretion by mineralocorticoid receptor-mediated signaling. J Endocrinol 232(3):525\u2013534","journal-title":"J Endocrinol"},{"issue":"3","key":"5222_CR14","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/cphy.c130037","volume":"4","author":"WB Bollag","year":"2014","unstructured":"Bollag WB (2014) Regulation of aldosterone synthesis and secretion. Compr Physiol 4(3):1017\u20131055","journal-title":"Compr Physiol"},{"issue":"2","key":"5222_CR15","first-page":"1","volume":"18","author":"NP Wang","year":"2017","unstructured":"Wang NP, Erskine J, Zhang WW, Zheng RH, Zhang LH, Duron G, Gendreau J, Zhao ZQ (2017) Recruitment of macrophages from the spleen contributes to myocardial fibrosis and hypertension induced by angiotensin II. J Renin Angiotensin Aldosterone Syst 18(2):1\u201314","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"3","key":"5222_CR16","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/cphy.c130050","volume":"4","author":"N Gallo-Payet","year":"2014","unstructured":"Gallo-Payet N, Battista MC (2014) Steroidogenesis-adrenal cell signal transduction. Compr Physiol 4(3):889\u2013964","journal-title":"Compr Physiol"},{"issue":"13","key":"5222_CR17","doi-asserted-by":"crossref","first-page":"7250","DOI":"10.1073\/pnas.96.13.7250","volume":"96","author":"HS Bose","year":"1999","unstructured":"Bose HS, Whittal RM, Baldwin MA, Miller WL (1999) The active form of the steroidogenic acute regulatory protein, StAR, appears to be a molten globule. Proc Natl Acad Sci USA 96(13):7250\u20137255","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"5222_CR18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1124\/mol.111.076471","volume":"81","author":"BP Adams","year":"2012","unstructured":"Adams BP, Bose HS (2012) Alteration in accumulated aldosterone synthesis as a result of N-terminal cleavage of aldosterone synthase. Mol Pharmacol 81(3):465\u2013474","journal-title":"Mol Pharmacol"},{"key":"5222_CR19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/bs.vh.2018.10.003","volume":"109","author":"MJ Young","year":"2019","unstructured":"Young MJ, Adler GK (2019) Aldosterone, the mineralocorticoid receptor and mechanisms of cardiovascular disease. Vitam Horm 109:361\u2013385","journal-title":"Vitam Horm"},{"issue":"6","key":"5222_CR20","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1161\/HYPERTENSIONAHA.117.09791","volume":"70","author":"E Mart\u00ednez-Mart\u00ednez","year":"2017","unstructured":"Mart\u00ednez-Mart\u00ednez E, Buonafine M, Boukhalfa I, Ibarrola J, Fern\u00e1ndez-Celis A, Kolkhof P, Rossignol P, Girerd N, Mulder P, L\u00f3pez-Andr\u00e9s N, Ouvrard-Pascaud A, Jaisser F (2017) Aldosterone target NGAL (neutrophil gelatinase-associated lipocalin) is involved in cardiac remodeling after myocardial infarction through NF\u03baB pathway. Hypertension 70(6):1148\u20131156","journal-title":"Hypertension"},{"issue":"4","key":"5222_CR21","doi-asserted-by":"crossref","first-page":"F932","DOI":"10.1152\/ajprenal.00252.2009","volume":"297","author":"V Ram\u00edrez","year":"1986","unstructured":"Ram\u00edrez V, Trujillo J, Valdes R, Uribe N, Cruz C, Gamba G et al (1986) Adrenalectomy prevents renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 297(4):F932\u2013F942","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"5222_CR22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0014-5793(86)81553-8","volume":"208","author":"WS Young","year":"1986","unstructured":"Young WS (1986) Corticotropin-releasing factor mRNA in the hypothalamus is affected differently by drinking saline and by dehydration. FEBS Lett 208(1):158\u2013162","journal-title":"FEBS Lett"},{"issue":"1\u20132","key":"5222_CR23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000335559","volume":"89","author":"T Nariai","year":"2012","unstructured":"Nariai T, Fujita K, Mori M, Katayama S, Hori S, Matsui K (2012) Antihypertensive and cardiorenal protective effects of SM-368229, a novel mineralocorticoid receptor antagonist, in aldosterone\/salt-treated rats. Pharmacology 89(1\u20132):44\u201352","journal-title":"Pharmacology"},{"issue":"1","key":"5222_CR24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jtcvs.2007.11.016","volume":"136","author":"M Tsukashita","year":"2008","unstructured":"Tsukashita M, Marui A, Nishina T, Yoshikawa E, Kanemitsu H, Wang J, Ikeda T, Komeda M (2008) Spironolactone alleviates late cardiac remodeling after left ventricular restoration surgery. J Thorac Cardiovasc Surg 136(1):58\u201364","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1\u20133","key":"5222_CR25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2008.12.049","volume":"606","author":"X Gao","year":"2009","unstructured":"Gao X, He X, Luo B, Peng L, Lin J, Zuo Z (2009) Angiotensin II increases collagen I expression via transforming growth factor-beta1 and extracellular signal-regulated kinase in cardiac fibroblasts. Eur J Pharmacol 606(1\u20133):115\u2013120","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"5222_CR26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mce.2011.07.034","volume":"350","author":"NG Hattangady","year":"2012","unstructured":"Hattangady NG, Olala LO, Bollag WB, Rainey WE (2012) Acute and chronic regulation of aldosterone production. Mol Cell Endocrinol 350(2):151\u2013162","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"5222_CR27","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/en.2008-1036","volume":"150","author":"JM Rincon Garriz","year":"2009","unstructured":"Rincon Garriz JM, Suarez C, Capponi AM (2009) c-Fos mediates angiotensin II-induced aldosterone production and protein synthesis in bovine adrenal glomerulosa cells. Endocrinology 150(3):1294\u20131302","journal-title":"Endocrinology"},{"issue":"11","key":"5222_CR28","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1210\/en.2003-0325","volume":"144","author":"N Cherradi","year":"2003","unstructured":"Cherradi N, Pardo B, Greenberg AS, Kraemer FB, Capponi AM (2003) Angiotensin II activates cholesterol ester hydrolase in bovine adrenal glomerulosacells through phosphorylation mediated by p42\/p44 mitogen-activated protein kinase. Endocrinology 144(11):905\u2013915","journal-title":"Endocrinology"},{"issue":"4","key":"5222_CR29","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/01.HYP.36.4.495","volume":"36","author":"Y Takeda","year":"2000","unstructured":"Takeda Y, Yoneda T, Demura M, Miyamori I, Mabuchi H (2000) Cardiac aldosterone production in genetically hypertensive rats. Hypertension 36(4):495\u2013500","journal-title":"Hypertension"},{"key":"5222_CR30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.yjmcc.2015.05.019","volume":"85","author":"O Adam","year":"2015","unstructured":"Adam O, Zimmer C, Hanke N, Hartmann RW, Klemmer B, B\u00f6hm M, Laufs U (2015) Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice. J Mol Cell Cardiol 85:140\u2013150","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"5222_CR31","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/aps.2011.179","volume":"33","author":"JY Li","year":"2012","unstructured":"Li JY, Zhang SL, Ren M, Wen YL, Yan L, Cheng H (2012) High-sodium intake aggravates myocardial injuries induced by aldosterone via oxidative stress in Sprague\u2013Dawley rats. Acta Pharmacol Sin 33(3):393\u2013400","journal-title":"Acta Pharmacol Sin"},{"key":"5222_CR32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijcard.2017.01.013","volume":"232","author":"V Marzolla","year":"2017","unstructured":"Marzolla V, Armani A, Mammi C, Moss ME, Pagliarini V, Pontecorvo L, Antelmi A, Fabbri A, Rosano G, Jaffe IZ, Caprio M (2017) Essential role of ICAM-1 in aldosterone-induced atherosclerosis. Int J Cardiol 232:233\u2013242","journal-title":"Int J Cardiol"},{"issue":"11","key":"5222_CR33","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/1440-1681.12473","volume":"42","author":"JN Minas","year":"2015","unstructured":"Minas JN, Thorwald MA, Conte D, V\u00e1zquez-Medina JP, Nishiyama A, Ortiz RM (2015) Angiotensin and mineralocorticoid receptor antagonism attenuatescardiac oxidative stress in angiotensin II-infused rats. Clin Exp Pharmacol Physiol 42(11):1178\u20131188","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"6","key":"5222_CR34","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1182\/blood-2005-10-009191","volume":"108","author":"JS Kim","year":"2006","unstructured":"Kim JS, Kim JG, Moon MY, Jeon CY, Won HY, Kim HJ, Jeon YJ, Seo JY, Kim JI, Kim J, Lee JY, Kim PH, Park JB (2006) Transforming growth factor beta1 regulates macrophage migration viaRhoA. Blood 108(6):1821\u20131829","journal-title":"Blood"},{"issue":"6","key":"5222_CR35","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/dvdy.22280","volume":"239","author":"JJ Santiago","year":"2010","unstructured":"Santiago JJ, Dangerfield AL, Rattan SG, Bathe KL, Cunnington RH, Raizman JE, Bedosky KM, Freed DH, Kardami E, Dixon IM (2010) Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts. Dev Dyn 239(6):1573\u20131584","journal-title":"Dev Dyn"},{"issue":"10","key":"5222_CR36","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.3390\/ijms18102157","volume":"18","author":"E Pardali","year":"2017","unstructured":"Pardali E, Sanchez-Duffhues G, Gomez-Puerto MC, Ten Dijke PT (2017) TGF-\u03b2-induced endothelial-mesenchymal transition in fibrotic diseases. Int J Mol Sci 18(10):2157\u20132167","journal-title":"Int J Mol Sci"},{"issue":"10","key":"5222_CR37","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1172\/JCI94753","volume":"127","author":"H Khalil","year":"2017","unstructured":"Khalil H, Kanisicak O, Prasad V, Correll RN, Fu X, Schips T, Vagnozzi RJ, Liu R, Huynh T, Lee SJ, Karch J, Molkentin JD (2017) Fibroblast-specific TGF-\u03b2 Smad2\/3 signaling underlies cardiacfibrosis. J Clin Invest 127(10):3770\u20133783","journal-title":"J Clin Invest"},{"issue":"6","key":"5222_CR38","doi-asserted-by":"crossref","first-page":"H1426","DOI":"10.1152\/ajpheart.00772.2018","volume":"316","author":"N Escobales","year":"2019","unstructured":"Escobales N, Nu\u00f1ez RE, Javadov S (2019) Mitochondrial angiotensin receptors and cardioprotective pathways. Am J Physiol Heart Circ Physiol 316(6):H1426\u2013H1438","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"5222_CR39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1172\/JCI93561","volume":"128","author":"DJ Tschumperlin","year":"2018","unstructured":"Tschumperlin DJ, Ligresti G, Hilscher MB, Shah VH (2018) Mechanosensing and fibrosis. J Clin Invest 128(1):74\u201384","journal-title":"J Clin Invest"},{"key":"5222_CR40","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.2147\/DDDT.S144807","volume":"11","author":"WW Zhang","year":"2017","unstructured":"Zhang WW, Bai F, Wang J, Zheng RH, Yang LW, James EA, Zhao ZQ (2017) Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor. Drug Des Dev Ther 11:3019\u20133033","journal-title":"Drug Des Dev Ther"},{"issue":"1","key":"5222_CR41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/1573403X14666180111145207","volume":"14","author":"AM Rababa'h","year":"2018","unstructured":"Rababa\u2019h AM, Guillory AN, Mustafa R, Hijjawi T (2018) Oxidative stress and cardiac remodeling: an updated edge. Curr Cardiol Rev 14(1):53\u201359","journal-title":"Curr Cardiol Rev"},{"issue":"5","key":"5222_CR42","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1172\/JCI87491","volume":"127","author":"NG Frangogiannis","year":"2017","unstructured":"Frangogiannis NG (2017) The extracellular matrix in myocardial injury, repair, and remodeling. J Clin Invest 127(5):1600\u20131612","journal-title":"J Clin Invest"},{"issue":"4","key":"5222_CR43","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1046\/j.1523-1755.2000.00973.x","volume":"57","author":"C Delcayre","year":"2000","unstructured":"Delcayre C, Silvestre JS, Garnier A, Oubenaissa A, Cailmail S, Tatara E, Swynghedauw B, Robert V (2000) Cardiac aldosterone production and ventricular remodeling. Kidney Int 57(4):1346\u20131351","journal-title":"Kidney Int"},{"issue":"42","key":"5222_CR44","doi-asserted-by":"crossref","first-page":"67828","DOI":"10.18632\/oncotarget.12182","volume":"7","author":"MN Hong","year":"2016","unstructured":"Hong MN, Li XD, Chen DR, Ruan CC, Xu JZ, Chen J, Wu YJ, Ma Y, Zhu DL, Gao PJ (2016) Renal denervation attenuates aldosterone expression and associated cardiovascular pathophysiology in angiotensin II-induced hypertension. Oncotarget 7(42):67828\u201367840","journal-title":"Oncotarget"},{"issue":"8","key":"5222_CR45","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1111\/j.1476-5381.2012.01953.x","volume":"166","author":"H M\u00fcller-Fielitz","year":"2012","unstructured":"M\u00fcller-Fielitz H, Lau M, J\u00f6hren O, Stellmacher F, Schwaninger M, Raasch W (2012) Blood pressure response to angiotensin II is enhanced in obese Zucker rats and is attributed to an aldosterone-dependent mechanism. Br J Pharmacol 166(8):2417\u20132429","journal-title":"Br J Pharmacol"},{"issue":"6","key":"5222_CR46","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41440-018-0037-1","volume":"41","author":"K Bokuda","year":"2018","unstructured":"Bokuda K, Morimoto S, Seki Y, Yatabe M, Watanabe D, Yatabe J, Ando T, Shimizu S, Itoh H, Ichihara A (2018) Greater reductions in plasma aldosterone with aliskiren in hypertensive patients with higher soluble (Pro) renin receptor level. Hypertens Res 41(6):435\u2013443","journal-title":"Hypertens Res"},{"issue":"7","key":"5222_CR47","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.amjmed.2018.02.025","volume":"131","author":"MS Maron","year":"2018","unstructured":"Maron MS, Chan RH, Kapur NK, Jaffe IZ, McGraw AP, Kerur R, Maron BJ, Udelson JE (2018) Effect of spironolactone on myocardial fibrosis and other clinical variables in patients with hypertrophic cardiomyopathy. Am J Med 131(7):837\u2013841","journal-title":"Am J Med"},{"issue":"9","key":"5222_CR48","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/ejhf.792","volume":"19","author":"A Olivier","year":"2017","unstructured":"Olivier A, Pitt B, Girerd N, Lamiral Z, Machu JL, McMurray JJV, Swedberg K, van Veldhuisen DJ, Collier TJ, Pocock SJ, Rossignol P, Zannad F, Pizard A (2017) Effect of eplerenone in patients with heart failure and reduced ejectionfraction: potential effect modification by abdominal obesity. Insight from the EMPHASIS-HF trial. Eur J Heart Fail 19(9):1186\u20131197","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"5222_CR49","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cardfail.2018.03.002","volume":"24","author":"AS Desai","year":"2018","unstructured":"Desai AS, Liu J, Pfeffer MA, Claggett B, Fleg J, Lewis EF, McKinlay S, O\u2019Meara E, Shah SJ, Sweitzer NK, Solomon S, Pitt B (2018) Incident hyperkalemia, hypokalemia, and clinical outcomes during spironolactone treatment of heart failure with preserved ejection fraction: analysis of the TOPCAT trial. J Card Fail 24(5):313\u2013320","journal-title":"J Card Fail"},{"issue":"1","key":"5222_CR50","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10557-017-6767-5","volume":"32","author":"J Tamargo","year":"2018","unstructured":"Tamargo J, Caballero RE, Delp\u00f3n E (2018) New therapeutic approaches for the treatment of hyperkalemia in patients treated with renin\u2013angiotensin\u2013aldosterone system inhibitors. Cardiovasc Drugs Ther 32(1):99\u2013119","journal-title":"Cardiovasc Drugs Ther"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-019-05222-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-019-05222-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-019-05222-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T01:13:12Z","timestamp":1607389992000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-019-05222-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,9]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["5222"],"URL":"https:\/\/doi.org\/10.1007\/s11033-019-05222-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,9]]},"assertion":[{"value":"26 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declared no conflict of interest with respect to the authorships, research, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}